AI in Healthcare: Investors Explore a Hot New Topic at RESI SF

6 Dec

By Lucy Parkinson, VP of Investor Research, LSN

Artificial intelligence is widely seen as the new frontier of tech innovation, and many applications for the technology have been found in healthcare.  Scientist-entrepreneurs are exploring AI diagnostics, AI drug discovery, AI imaging analysis, AI for personalized medicine, and more.  At RESI San Francisco, a panel of investors who focus on this field will discuss how they see the risks and opportunities that are arising for AI in healthcare.

The panelists are:

  • Elaine Mo, Ascend Capital Partners
  • Edward Kliphuis, M Ventures
  • Armen Vidian, Data Collective
  • Lu Zhang, Fusion Fund
  • Yizhen Dong, 11.2 Capital

Panelists will discuss what they’re looking for when they evaluate an AI opportunity, what challenges (including regulatory) they see on the horizon, and where they see the real potential for AI technologies in health.  Join us at RESI to see this panel live.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: